14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
HOTH vs GNPX: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Hoth Therapeutics, Inc. (HOTH) is the stronger overall head-to-head candidate over Genprex, Inc. (GNPX) in the Tradestie Institutional Equity Comparison Engine, winning 4–1 core matrix metrics and 3–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). HOTH carries a Unified Composite Score of 51.1/100 (HOLD) at $1.36 (N/M Forward P/E, 0.0% operating margin), whereas GNPX carries 42.2/100 (HOLD) at $1.45 (N/M Forward P/E, 0.0% operating margin).
Technical & Structure Timing Caution: HOTH trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 84.6); meanwhile GNPX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 26.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HOTH vs GNPX. Trailing 12-month operating profitability (HOTH 0.0% vs GNPX 0.0%) and valuation multiples (HOTH N/M vs GNPX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Biotechnology value chain with $2.2M market capitalization and 0.0% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ HOTH vs GNPX Key Questions & Quantitative Answers
As of Nov 20, 2026, Hoth Therapeutics, Inc. (HOTH) is the stronger overall head-to-head candidate over Genprex, Inc. (GNPX) in the Tradestie Institutional Equity Comparison Engine, winning 4–1 core matrix metrics and 3–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). HOTH carries a Unified Composite Score of 51.1/100 (HOLD) at $1.36 (N/M Forward P/E, 0.0% operating margin), whereas GNPX carries 42.2/100 (HOLD) at $1.45 (N/M Forward P/E, 0.0% operating margin). Technical & Structure Timing Caution: HOTH trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 84.6); meanwhile GNPX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 26.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
HOTH leads the Growth & Scale pillar: HOTH posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with GNPX at +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, HOTH generates N/A in USD-normalized revenue versus N/A for GNPX. In operating R&D and SG&A reinvestment, HOTH deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for GNPX.
HOTH and GNPX trade at balanced relative valuation multiples. HOTH trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin), whereas GNPX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against HOTH (-191.4% ROE) versus GNPX (-233.7% ROE) capital efficiency.
In options market volatility and institutional positioning, HOTH carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.92β · 324% Vol realized risk). By comparison, GNPX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-4.68β · 96% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.